Real-world use of the IBD disk tool in unselected cohorts of outpatients

被引：0
|
作者：
Sharma, N. [1 ]
Savelkoul, E. [2 ]
Disney, B. [3 ]
Shah, A. [4 ]
De Silva, S. [5 ]
Pattni, S. [6 ]
Iacucci, M. [7 ]
Cooney, R. [8 ]
Ghosh, S. [9 ]
机构：
[1] Univ Birmingham, Inst Immunol & Immunotherapy, Gastroenterol, Birmingham, W Midlands, England
[2] Radboudumc, Gastroenterol, Nijmegen, Netherlands
[3] Univ Hosp Coventry & Warwickshire, Gastroenterol, Coventry, W Midlands, England
[4] Royal Wolverhampton NHS Trust, Gastroenterol, Wolverhampton, England
[5] Dudley Grp NHS Fdn Trust, Gastroenterol, Dudley, England
[6] Univ Hosp Leicester NHS Trust, Gastroenterol, Leicester, Leics, England
[7] Univ Birmiingham, Inst Translat Med, Inst Immunol & Immunotherapy, NIHR Biomed Res Ctr, Birmingham, W Midlands, England
[8] Queen Elizabeth Hosp Birmingham, Gastroenterol, Birmingham, W Midlands, England
[9] NIHR Birmingham Biomed Res Ctr, Inst Translat Med, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England
来源：
JOURNAL OF CROHNS & COLITIS | 2020年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P121
引用
收藏
页码：S196 / S197
页数：2
相关论文
共 50 条
  • [21] Real-World Use of Iron Chelators
    Kwiatkowski, Janet L.
    [J]. HEMATOLOGY-AMERICAN SOCIETY OF HEMATOLOGY EDUCATION PROGRAM, 2011, : 451 - 458
  • [22] External validation of lung function predictions in real-world cohorts of COPD
    Zafari, Zafar
    Lee, Tsung-Ying
    Satadsafavi, Mohsen
    [J]. RESPIRATORY MEDICINE, 2022, 198
  • [23] REAL-WORLD OUTCOMES AFTER VEDOLIZUMAB DISCONTINUATION IN A TERTIARY IBD COHORT
    Sebepos-Rogers, Gregory
    Fragkos, Konstantinos
    Saravanapavan, Hajeena
    Barragry, John
    Koo, Hui Fen
    Ko, Ho Juen
    Parisi, Ioanna
    Seward, Edward
    McCartney, Sara
    Bloom, Stuart
    Mehta, Shameer
    Rahman, Farooq
    [J]. GUT, 2021, 70 : A81 - A82
  • [24] REAL-WORLD EXPERIENCE OF SUBCUTANEOUS VEDOLIZUMAB FOR TREATMENT OF IBD IN NHS TAYSIDE
    McLean, Mairi
    Cartlidge, Peter
    Fyall, Julie
    Paterson, Jacqueline
    Mowat, Craig
    Groome, Max
    McLean, Mairi H.
    [J]. GUT, 2022, 71 : A58 - A59
  • [25] Predicting real-world functioning in outpatients with schizophrenia: Role of inflammation and psychopathology
    Gonzalez-Blanco, Leticia
    Paz Garcia-Portilla, Maria
    Dal Santo, Francesco
    Garcia-Alvarez, Leticia
    de la Fuente-Tomas, Lorena
    Menendez-Miranda, Isabel
    Bobes-Bascaran, Teresa
    Saiz, Pilar A.
    Bobes, Julio
    [J]. PSYCHIATRY RESEARCH, 2019, 280
  • [26] The impact of dose on the real-world effectiveness of vortioxetine in outpatients with mdd in greece
    Papalexi, E.
    Kakkavas, P.
    Vassos, D.
    Mylonaki, T.
    Partsafyllidis, D.
    Mageiria, S.
    Nestoris, C.
    Galanopoulos, A.
    Ettrup, A.
    [J]. EUROPEAN PSYCHIATRY, 2021, 64 : S337 - S338
  • [27] Driving performance of stable outpatients with depression undergoing real-world treatment
    Miyata, Akemi
    Iwamoto, Kunihiro
    Kawano, Naoko
    Aleksic, Branko
    Ando, Masahiko
    Ebe, Kazutoshi
    Fujita, Kiyoshi
    Yokoyama, Motonori
    Akiyama, Tsuyoshi
    Igarashi, Yoshio
    Ozaki, Norio
    [J]. PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2018, 72 (06) : 399 - 408
  • [28] Characterizing Dual Combination Therapy Use In Treatment Escalation Of Hypertension: Real-world Evidence From Multinational Cohorts
    Lu, Yuan
    Li, Jing
    Wang, Xialin
    Dorajoo, Sreemanee
    Feng, Mengling
    Hsu, Min-Huei
    Hsu, Jason C. C.
    Hwang, Jiyoung
    Iqbal, Usman
    Chen, Zhengfeng J.
    Jonnagaddala, Jitendra
    [J]. CIRCULATION, 2021, 144
  • [29] OUTCOMES OF BIOSIMILAR ADALIMUMAB SWITCHBACKS/REVERSE SWITCHING IN IBD: REAL-WORLD EXPERIENCE
    Norredinvand, Hesam Ahmadi
    Bishop, Sophia
    Patel, Janki
    Sivanesan, Naveenaa
    Fong, Steven
    [J]. GUT, 2021, 70 : A94 - A94
  • [30] Real-World Success of Biologic Therapy in IBD: No More Reasons to Be Anti Antibody
    Gordon, Neil
    Sebastian, Shaji
    [J]. DIGESTIVE DISEASES AND SCIENCES, 2019, 64 (03) : 614 - 615
12345